糖尿病与新冠病毒：不仅仅是两种疾病的叠加。
Diabetes and covid-19: more than the sum of two morbidities.
机构信息
Departamento de Medicina Preventiva, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brasil.
Faculdade de Saúde Pública, Universidade de São Paulo, São Paulo, SP, Brasil.
出版信息
Rev Saude Publica. 2020;54:54. doi: 10.11606/s1518-8787.2020054002577. Epub 2020 May 29.
Abstract
The coronavirus disease 2019 (covid-19) pandemic has caused a public health emergency worldwide. Risk, severity and mortality of the disease have been associated with non-communicable chronic diseases, such as diabetes mellitus. Accumulated evidence has caused great concern in countries with high prevalence of this morbidity, such as Brazil. This text shows the picture of diabetes in Brazil, followed by epidemiological data and explanatory hypothesis for the association between diabetes and covid-19. We emphasized how the burden of these two morbidities in a middle-income country has aggravated this pandemic scenario. The comprehension of this association and biological plausibility may help face this pandemic and future challenges.
摘要
2019 年冠状病毒病（COVID-19）大流行已在全球范围内引发公共卫生紧急事件。该疾病的风险、严重程度和死亡率与非传染性慢性病有关，例如糖尿病。积累的证据引起了高发病率国家的极大关注，例如巴西。本文展示了巴西的糖尿病情况，随后是流行病学数据和对糖尿病与 COVID-19 之间关联的解释性假设。我们强调了中等收入国家的这两种疾病负担如何加剧了这种大流行情况。对这种关联的理解和生物学合理性可能有助于应对这一大流行和未来的挑战。
相似文献
1
Diabetes and covid-19: more than the sum of two morbidities.糖尿病与新冠病毒：不仅仅是两种疾病的叠加。
Rev Saude Publica. 2020;54:54. doi: 10.11606/s1518-8787.2020054002577. Epub 2020 May 29.
2
Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.中国武汉 140 名 SARS-CoV-2 感染患者的临床特征。
Allergy. 2020 Jul;75(7):1730-1741. doi: 10.1111/all.14238. Epub 2020 Feb 27.
3
Diabetes mellitus: Lessons from the COVID-19 pandemic.糖尿病：来自COVID-19大流行的经验教训。
Hellenic J Cardiol. 2020 Jan-Feb;61(1):1-2. doi: 10.1016/j.hjc.2020.03.009. Epub 2020 May 18.
4
Characteristics and outcomes of diabetic patients infected by the SARS-CoV-2.感染新型冠状病毒的糖尿病患者的特征与结局
Pan Afr Med J. 2020 Sep 8;37:32. doi: 10.11604/pamj.2020.37.32.25192. eCollection 2020.
5
Prevalence and impact of diabetes among people infected with SARS-CoV-2.2019冠状病毒病感染者中糖尿病的患病率及影响
J Endocrinol Invest. 2020 Jun;43(6):867-869. doi: 10.1007/s40618-020-01236-2. Epub 2020 Mar 28.
6
COVID-19: Considerations of Diabetes and Cardiovascular Disease Management.2019冠状病毒病：糖尿病与心血管疾病管理的考量
J Diabetes Sci Technol. 2020 Jul;14(4):723-724. doi: 10.1177/1932296820930025. Epub 2020 May 30.
7
Population-based Estimates for High Risk of Severe COVID-19 Disease due to Age and Underlying Health Conditions.基于人群的因年龄和基础健康状况导致的重症 COVID-19 疾病高风险估计。
Acta Med Port. 2020 Nov 2;33(11):720-725. doi: 10.20344/amp.14222. Epub 2020 Jul 24.
8
Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia - A systematic review, meta-analysis, and meta-regression.糖尿病与COVID-19肺炎患者的死亡率增加及疾病严重程度相关——一项系统评价、荟萃分析和Meta回归分析
Diabetes Metab Syndr. 2020 Jul-Aug;14(4):395-403. doi: 10.1016/j.dsx.2020.04.018. Epub 2020 Apr 17.
9
Is diabetes mellitus a risk factor for COronaVIrus Disease 19 (COVID-19)?糖尿病是否是 2019 年冠状病毒病（COVID-19）的危险因素？
Acta Diabetol. 2020 Nov;57(11):1275-1285. doi: 10.1007/s00592-020-01586-6. Epub 2020 Aug 31.
10
Prevalence and characterization of asthma in hospitalized and nonhospitalized patients with COVID-19.COVID-19 住院和非住院患者中哮喘的患病率和特征。
J Allergy Clin Immunol. 2020 Aug;146(2):307-314.e4. doi: 10.1016/j.jaci.2020.06.010. Epub 2020 Jun 15.
引用本文的文献
1
An Overview of SARS-CoV-2 Etiopathogenesis and Recent Developments in COVID-19 Vaccines.SARS-CoV-2 的发病机制概述及 COVID-19 疫苗的最新进展。
Biomolecules. 2023 Oct 24;13(11):1565. doi: 10.3390/biom13111565.
2
COVID-19 signalome: Pathways for SARS-CoV-2 infection and impact on COVID-19 associated comorbidity.COVID-19 信号通路：SARS-CoV-2 感染途径及其对 COVID-19 相关合并症的影响。
Cell Signal. 2023 Jan;101:110495. doi: 10.1016/j.cellsig.2022.110495. Epub 2022 Oct 15.
3
Assisting individuals with diabetes in the COVID-19 pandemic period: Examining the role of religious factors and faith communities.在2019冠状病毒病大流行期间协助糖尿病患者：审视宗教因素和宗教团体的作用。
World J Clin Cases. 2022 Sep 16;10(26):9180-9191. doi: 10.12998/wjcc.v10.i26.9180.
4
Effect of an app on students' knowledge about diabetes during the COVID-19 pandemic.新冠疫情期间，一款应用对学生糖尿病知识的影响。
Rev Lat Am Enfermagem. 2022;30:e3595. doi: 10.1590/1518-8345.5798.3595.
5
Corticosteroids for COVID-19 Therapy: Potential Implications on Tuberculosis.COVID-19 治疗中的皮质类固醇：对结核病的潜在影响。
Int J Mol Sci. 2021 Apr 6;22(7):3773. doi: 10.3390/ijms22073773.
6
Bidirectional link between diabetes mellitus and coronavirus disease 2019 leading to cardiovascular disease: A narrative review.2型糖尿病与2019冠状病毒病之间导致心血管疾病的双向联系：一项叙述性综述。
World J Diabetes. 2021 Mar 15;12(3):215-237. doi: 10.4239/wjd.v12.i3.215.
7
COVID-19 and Vulnerable Populations in Sub-Saharan Africa.撒哈拉以南非洲的 COVID-19 和脆弱人群。
Adv Exp Med Biol. 2021;1321:147-162. doi: 10.1007/978-3-030-59261-5_13.
8
Spotlight on Cardiovascular Scoring Systems in Covid-19: Severity Correlations in Real-world Setting.聚焦新冠病毒心血管评分系统：真实环境下的严重度相关性。
Curr Probl Cardiol. 2021 May;46(5):100819. doi: 10.1016/j.cpcardiol.2021.100819. Epub 2021 Feb 15.
9
COVID-19 associated with diabetes and other noncommunicable diseases led to a global health crisis.与糖尿病和其他非传染性疾病相关的新冠病毒病引发了一场全球健康危机。
Diabetes Res Clin Pract. 2021 Jan;171:108587. doi: 10.1016/j.diabres.2020.108587. Epub 2020 Dec 9.
10
Decentralized COVID-19 measures in Brazil were ineffective to protect people with diabetes.巴西的新冠疫情分散化措施对于保护糖尿病患者无效。
Diabetes Metab Syndr. 2020 Nov-Dec;14(6):1973-1978. doi: 10.1016/j.dsx.2020.10.005. Epub 2020 Oct 7.
本文引用的文献
1
Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 - COVID-NET, 14 States, March 1-30, 2020.2020 年 3 月 1 日至 30 日，14 个州住院的经实验室确诊的 2019 冠状病毒病患者的住院率和特征 - COVID-NET。
MMWR Morb Mortal Wkly Rep. 2020 Apr 17;69(15):458-464. doi: 10.15585/mmwr.mm6915e3.
2
Obesity in Patients Younger Than 60 Years Is a Risk Factor for COVID-19 Hospital Admission.60岁以下患者的肥胖是COVID-19住院治疗的一个风险因素。
Clin Infect Dis. 2020 Jul 28;71(15):896-897. doi: 10.1093/cid/ciaa415.
3
Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.意大利伦巴第地区 1591 名 ICU 收治的 SARS-CoV-2 感染患者的基线特征和结局。
JAMA. 2020 Apr 28;323(16):1574-1581. doi: 10.1001/jama.2020.5394.
4
Potential Effects of Coronaviruses on the Cardiovascular System: A Review.冠状病毒对心血管系统的潜在影响：综述。
JAMA Cardiol. 2020 Jul 1;5(7):831-840. doi: 10.1001/jamacardio.2020.1286.
5
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素：一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
6
Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?高血压和糖尿病患者感染新型冠状病毒肺炎（COVID-19）的风险会增加吗？
Lancet Respir Med. 2020 Apr;8(4):e21. doi: 10.1016/S2213-2600(20)30116-8. Epub 2020 Mar 11.
7
Clinical Characteristics of Coronavirus Disease 2019 in China.《中国 2019 年冠状病毒病临床特征》
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.
8
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.中国武汉严重 COVID-19 患者的临床病程和结局：一项单中心、回顾性、观察性研究。
Lancet Respir Med. 2020 May;8(5):475-481. doi: 10.1016/S2213-2600(20)30079-5. Epub 2020 Feb 24.
9
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.中国2019年冠状病毒病（COVID-19）疫情的特征及重要经验教训：来自中国疾病预防控制中心72314例病例报告的总结
JAMA. 2020 Apr 7;323(13):1239-1242. doi: 10.1001/jama.2020.2648.
10
Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.中国武汉 140 名 SARS-CoV-2 感染患者的临床特征。
Allergy. 2020 Jul;75(7):1730-1741. doi: 10.1111/all.14238. Epub 2020 Feb 27.
Zotero 插件